MAKE A DIFFERENCE, HELP FIGHT DIPG
MAKE A DIFFERENCE, HELP FIGHT DIPG
On March 29th Hollis was diagnosed with Diffuse Intrinsic Pontine Glioma (DIPG). He fought a 9 month battle with the disease. On January 2, 2017 he ran home to Heaven. His family has partnered with TGen, Translational Genomics Research Institute, to fund ground breaking research towards finding a cure for DIPG.
DIPG, Diffuse intrinsic pontine glioma (dih-FYOOS in-TRIN-sik PON-teen glee-OH-muh)
300 - 500 children diagnosed in the United States each year. Average survival is one year from diagnosis. There is less than 1% survival rate 2 years from diagnosis
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
THANK YOU TO OUR SPONSORS! By participating you are helping to accelerate research of DIPG, an aggressive pediatric brain cancer, at the Translational Genomics Research Institute (TGen).